Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus
Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus
复制标题
DOI:
10.1191/096120399678847678
复制
发表时间:
1999-01-01
期刊:
影响因子:
2.6
通讯作者:
Kashiwazaki, S
中科院分区:
文献类型:
--
作者:
Harigai, M;Hara, M;Kashiwazaki, S
Objective: To investigate the immunopathological significance of CD40/CD40 ligand system for B cell hyperactivation in SLE patients, the expression and the function of CD40 on B cells were compared with those of normal controls.Methods: Expression of CD40 was evaluated by flow cytometry. DNA synthesis of B cells were measured by H-3 - TdR incorporation. Antibody production was assessed by ELISA.Results: There was no significant difference between SLE and normal controls in CD40 expression on peripheral blood B cells. Recombinant CD40 ligand-leucine zipper fusion protein (CD40L-LZ) significantly enhanced 3H - TdR incorporation by both SLE and normal B cells (P < 0.01). H-3 - TdR incorporation of SLE B cells without stimuli (P < 0.001) and with CD40L-LZ stimulation (P < 0.05) were significantly lower in SLE patients compared with normal controls. Active SLE B cells spontaneously produced significantly larger amounts of total IgG than normal B cells (P < 0.05). CD40L-LZ significantly increased the production of total IgG by SLE B cells (P < 0.05), but not by normal B cells. Active SLE B cells spontaneously produced IgG anti-dsDNA and ISG anti-ssDNA antibodies. CD40L-LZ significantly increased the production of these autoantibodies by SLE B cells (P < 0.05). B cells from normal controls do not produce these autoantibodies spontaneously nor in response to CD40L-LZ.Conclusion: These findings indicate that signalling via CD40 plays an important role in B cell proliferation and autoantibody production in human SLE.